Ameriprise’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $131M | Buy |
1,414,886
+652,291
| +86% | +$65.5M | 0.03% | 477 |
|
|
2025
Q4 | $77.9M | Buy |
762,595
+455,114
| +148% | +$40.7M | 0.02% | 658 |
|
|
2025
Q3 | $19.2M | Sell |
307,481
-187,391
| -38% | -$10.2M | ﹤0.01% | 1433 |
|
|
2025
Q2 | $25.8M | Buy |
494,872
+331,823
| +204% | +$14.8M | 0.01% | 1201 |
|
|
2025
Q1 | $6.95M | Buy |
163,049
+7,884
| +5% | +$340K | ﹤0.01% | 2054 |
|
|
2024
Q4 | $4.74M | Buy |
155,165
+76,124
| +96% | +$2.14M | ﹤0.01% | 2393 |
|
|
2024
Q3 | $1.81M | Buy |
79,041
+7,012
| +10% | +$198K | ﹤0.01% | 2963 |
|
|
2024
Q2 | $2.08M | Buy |
72,029
+48,187
| +202% | +$1.12M | ﹤0.01% | 2846 |
|
|
2024
Q1 | $492K | Sell |
23,842
-458,154
| -95% | -$9.82M | ﹤0.01% | 3422 |
|
|
2023
Q4 | $13M | Buy |
481,996
+62,993
| +15% | +$1.65M | ﹤0.01% | 1575 |
|
|
2023
Q3 | $12.4M | Buy |
419,003
+32,364
| +8% | +$1.14M | ﹤0.01% | 1531 |
|
|
2023
Q2 | $13.8M | Buy |
+386,639
| New | +$11.1M | ﹤0.01% | 1515 |
|
|
2022
Q4 | – | Sell |
-9,917
| Closed | -$534K | – | 3998 |
|
|
2022
Q3 | $534K | Buy |
9,917
+101
| +1% | +$5.18K | ﹤0.01% | 3370 |
|
|
2022
Q2 | $396K | Buy |
9,816
+4,787
| +95% | +$237K | ﹤0.01% | 3474 |
|
|
2022
Q1 | $333K | Sell |
5,029
-3,797
| -43% | -$260K | ﹤0.01% | 3606 |
|
|
2021
Q4 | $883K | Buy |
8,826
+1,987
| +29% | +$206K | ﹤0.01% | 3314 |
|
|
2021
Q3 | $855K | Sell |
6,839
-13,797
| -67% | -$1.64M | ﹤0.01% | 3229 |
|
|
2021
Q2 | $2.56M | Sell |
20,636
-9,971
| -33% | -$1.34M | ﹤0.01% | 2824 |
|
|
2021
Q1 | $4.67M | Sell |
30,607
-14,345
| -32% | -$2.17M | ﹤0.01% | 2430 |
|
|
2020
Q4 | $5.79M | Sell |
44,952
-688,302
| -94% | -$79.2M | ﹤0.01% | 2168 |
|
|
2020
Q3 | $81.9M | Sell |
733,254
-207,756
| -22% | -$19M | 0.03% | 483 |
|
|
2020
Q2 | $76.3M | Sell |
941,010
-361,541
| -28% | -$29.1M | 0.03% | 469 |
|
|
2020
Q1 | $90.6M | Sell |
1,302,551
-130,687
| -9% | -$10M | 0.05% | 359 |
|
|
2019
Q4 | $112M | Buy |
1,433,238
+97,936
| +7% | +$7.06M | 0.05% | 383 |
|
|
2019
Q3 | $85.2M | Buy |
1,335,302
+35,730
| +3% | +$3.15M | 0.04% | 462 |
|
|
2019
Q2 | $112M | Buy |
1,299,572
+747,385
| +135% | +$57.1M | 0.05% | 379 |
|
|
2019
Q1 | $42.3M | Buy |
552,187
+464,153
| +527% | +$25.7M | 0.02% | 725 |
|
|
2018
Q4 | $3.31M | Buy |
+88,034
| New | +$3.24M | ﹤0.01% | 2387 |
|
Other funds holding GH
VPM
VCM
Ameriprise's GH Position: Q1 2026 in Review
Ameriprise increased its Guardant Health (GH) stake by 86% in Q1 2026, buying an estimated $65.5M and bringing the position to 1,414,886 shares worth $131M. The position accounts for 0.03% of the portfolio, ranked #477.
Ameriprise first reported a position in GH in Q4 2018 and has held it in 28 quarters since. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.
- Ameriprise held 1,414,886 shares of Guardant Health worth $131M as of Q1 2026.
- Ameriprise bought 652,291 Guardant Health shares in Q1 2026, an estimated $65.5M.
- Guardant Health made up 0.03% of Ameriprise's portfolio in Q1 2026, its #477 holding.
- Ameriprise first reported a position in Guardant Health in Q4 2018 and has held it in 28 quarters since.
- 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.
Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.